Total Clarity Wealth Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-62
Closed -$3K 312
2021
Q4
$3K Buy
62
+5
+9% +$261 ﹤0.01% 869
2021
Q3
$4K Buy
+57
New +$4.34K ﹤0.01% 836
2021
Q2
Sell
-57
Closed -$4K 269
2021
Q1
$4K Buy
+57
New +$4.43K ﹤0.01% 712

Other funds holding CDNA

Total Clarity Wealth Management's CDNA Position: Q1 2022 in Review

Total Clarity Wealth Management sold out of CareDx (CDNA) in Q1 2022, closing a stake of 62 shares — an estimated $3K sold.

Total Clarity Wealth Management first reported a position in CDNA in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q3 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Total Clarity Wealth Management reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 62 CareDx shares in Q1 2022, an estimated $3K.
  • Total Clarity Wealth Management first reported a position in CareDx in Q1 2021 and held it in 3 quarters.
  • Total Clarity Wealth Management's CareDx position peaked at $4K in Q3 2021.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Total Clarity Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.